These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8335892)
21. Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3. Wagner R; Modrow S; Böltz T; Fliessbach H; Niedrig M; von Brunn A; Wolf H Arch Virol; 1992; 127(1-4):139-52. PubMed ID: 1456889 [TBL] [Abstract][Full Text] [Related]
22. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes. Chada S; DeJesus CE; Townsend K; Lee WT; Laube L; Jolly DJ; Chang SM; Warner JF J Virol; 1993 Jun; 67(6):3409-17. PubMed ID: 8497058 [TBL] [Abstract][Full Text] [Related]
23. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE; Abaitua F; Rodríguez D; Esteban M Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077 [TBL] [Abstract][Full Text] [Related]
24. Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Hart MK; Weinhold KJ; Scearce RM; Washburn EM; Clark CA; Palker TJ; Haynes BF Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9448-52. PubMed ID: 1946358 [TBL] [Abstract][Full Text] [Related]
25. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034 [TBL] [Abstract][Full Text] [Related]
26. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations. Newman MJ; Wu JY; Gardner BH; Anderson CA; Kensil CR; Recchia J; Coughlin RT; Powell MF Vaccine; 1997 Jun; 15(9):1001-7. PubMed ID: 9261947 [TBL] [Abstract][Full Text] [Related]
27. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses. Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325 [TBL] [Abstract][Full Text] [Related]
28. Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector. Gómez CE; Rodríguez D; Rodríguez JR; Abaitua F; Duarte C; Esteban M Vaccine; 2001 Dec; 20(5-6):961-71. PubMed ID: 11738764 [TBL] [Abstract][Full Text] [Related]
29. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203 [TBL] [Abstract][Full Text] [Related]
30. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120. Luo L; Li Y; Chang JS; Cho SY; Kim TY; Choi MJ; Cheong HS; Kim HJ; Ahn HJ; Min MK; Chun BH; Jung SM; Woo SG; Park SY; Kang CY Virology; 1998 Jan; 240(2):316-25. PubMed ID: 9454705 [TBL] [Abstract][Full Text] [Related]
31. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains. Kayman SC; Wu Z; Revesz K; Chen H; Kopelman R; Pinter A J Virol; 1994 Jan; 68(1):400-10. PubMed ID: 7504740 [TBL] [Abstract][Full Text] [Related]
32. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Takahashi H; Nakagawa Y; Yokomuro K; Berzofsky JA Int Immunol; 1993 Aug; 5(8):849-57. PubMed ID: 8398980 [TBL] [Abstract][Full Text] [Related]
33. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo. Nakagawa Y; Shimizu M; Norose Y; Takahashi M; Takahashi H Int Immunol; 2013 Jan; 25(1):11-24. PubMed ID: 22945875 [TBL] [Abstract][Full Text] [Related]
34. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700 [TBL] [Abstract][Full Text] [Related]
35. The multi-epitope polypeptide approach in HIV-1 vaccine development. Cano CA Genet Anal; 1999 Nov; 15(3-5):149-53. PubMed ID: 10596755 [TBL] [Abstract][Full Text] [Related]
36. Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses. Liu XS; Liu WJ; Zhao KN; Liu YH; Leggatt G; Frazer IH Immunol Cell Biol; 2002 Feb; 80(1):21-9. PubMed ID: 11869359 [TBL] [Abstract][Full Text] [Related]
37. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001 [TBL] [Abstract][Full Text] [Related]
38. Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Kameoka M; Nishino Y; Matsuo K; Ohara N; Kimura T; Yamazaki A; Yamada T; Ikuta K Vaccine; 1994 Feb; 12(2):153-8. PubMed ID: 8147098 [TBL] [Abstract][Full Text] [Related]
39. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165 [TBL] [Abstract][Full Text] [Related]
40. Induction of HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. Warner JF; Anderson CG; Laube L; Jolly DJ; Townsend K; Chada S; St Louis D AIDS Res Hum Retroviruses; 1991 Aug; 7(8):645-55. PubMed ID: 1931234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]